Cargando…
Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene, encoding an anion channel that conducts chloride and bicarbonate across epithelial membranes. Mutations that disrupt pre-mRNA splicing occur in >15% of CF cases....
Autores principales: | Michaels, Wren E, Bridges, Robert J, Hastings, Michelle L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367209/ https://www.ncbi.nlm.nih.gov/pubmed/32520327 http://dx.doi.org/10.1093/nar/gkaa490 |
Ejemplares similares
-
Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction
por: Wang, Lingyan, et al.
Publicado: (2020) -
iRAPs curb antisense transcription in E. coli
por: Magán, Andrés, et al.
Publicado: (2019) -
Targeting alternative splicing by RNAi: from the differential impact on splice variants to triggering artificial pre-mRNA splicing
por: Fuchs, Armin, et al.
Publicado: (2021) -
Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs
por: Pfafenrot, Christina, et al.
Publicado: (2021) -
Modeling splicing outcome by combining 5′ss strength and splicing regulatory elements
por: Müller, Lisa, et al.
Publicado: (2022)